Presidio Pharmaceuticals' Grant - II Round

Presidio Pharmaceuticals raised a round of funding on July 25, 2010. Investors include Qualifying Therapeutic Discovery Project.

Presidio Pharmaceuticals is a clinical-stage pharmaceutical company dedicated to the discovery and development of small-molecule antiviral therapeutics. Presidio's focus is on effective therapies for …

Articles about Presidio Pharmaceuticals' Grant - II Round: